Wuhan Keqian Biology Co (SHSE:688526) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688526 Wuhan Keqian Biology Co Ltd SHSE:688526
80 GF Score
Price ¥12.65
GF Value ¥16.91
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Wuhan Keqian Biology Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Wuhan Keqian Biology Co's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

SHSE:688526 vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Wuhan Keqian Biology Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuhan Keqian Biology Co Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wuhan Keqian Biology Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Wuhan Keqian Biology Co's Margin of Safety % (DCF FCF Based) falls into.


SHSE:688526
80GF Score
Wuhan Keqian Biology Co Ltd SHSE:688526
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Wuhan Keqian Biology Co (SHSE:688526) Overvalued in 2026?

Based on GuruFocus' analysis, Wuhan Keqian Biology Co stock appears to be undervalued. The current stock price of ¥12.65 is trading 25.2% below its estimated GF Value™ of ¥16.91. GuruFocus considers Wuhan Keqian Biology Co to be Modestly Undervalued.

Key valuation signals for SHSE:688526:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ¥16.91 vs. price of ¥12.65 (25.2% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688526 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wuhan Keqian Biology Co Business Description

Address No. 419, Gaoxin 2nd Road, Donghu New Technology Development Zone, Hubei Province, Wuhan, CHN, 430073
Wuhan Keqian Biology Co Ltd is engaged in research and development, production, sales and animal epidemic prevention technical services of veterinary biological products. The company's products include Combination plan; Vaccine for swine; Poultry vaccine; Pet vaccine; and Diagnostic reagent.
80GF Score

Get the complete analysis for SHSE:688526

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.65
Price
¥16.91
GF Value